| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.006 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.007 |
| mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.008 |
| mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
-0.39 |
0.008 |
| mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.009 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.01 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.01 |
| mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.01 |
| mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.01 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |